Tryp Therapeutics Receives Confirmation from FDA to Proceed with Phase 2a Study in Fibromyalgia Dec 2, 2021
What Is Nociplastic Pain, And Can It Be Treated With Psychedelics? Tryp Therapeutics Scientific Advisor Dr. Daniel Clauw… Nov 2, 2021
Tryp Therapeutics Submits IND Application For Phase 2a Clinical Trial In Eating Disorders Sep 22, 2021
Tryp Therapeutics Completes Psychotherapy Training for Phase 2a Study at the University of Florida Aug 24, 2021
Tryp Therapeutics Partners with Calvert Labs to Conduct Exploratory Studies for Proprietary Psilocybin Formulations Aug 10, 2021
Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Exploring Psilocybin Treatments in Underserved Indications Jul 30, 2021
